As of 2026-06-10, the Relative Valuation of Pfizer Inc (PFE) is 28.86 USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.60 USD, the upside of Pfizer Inc based on Relative Valuation is 12.7%.
The range of the Relative Valuation is 23.06 - 40.95 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 31.2x | 24.8x |
| Forward P/E multiples | 17.3x - 19.8x | 18.8x |
| Fair Price | 23.06 - 40.95 | 28.86 |
| Upside | -9.9% - 60.0% | 12.7% |
| Date | P/E |
| 2026-06-09 | 19.55 |
| 2026-06-08 | 19.49 |
| 2026-06-05 | 19.81 |
| 2026-06-04 | 19.55 |
| 2026-06-03 | 19.28 |
| 2026-06-02 | 19.44 |
| 2026-06-01 | 19.50 |
| 2026-05-29 | 19.92 |
| 2026-05-28 | 19.89 |
| 2026-05-27 | 19.94 |
| 2026-05-26 | 19.67 |
| 2026-05-22 | 19.71 |
| 2026-05-21 | 19.74 |
| 2026-05-20 | 19.62 |
| 2026-05-19 | 19.52 |
| 2026-05-18 | 19.27 |
| 2026-05-15 | 19.27 |
| 2026-05-14 | 19.59 |
| 2026-05-13 | 19.75 |
| 2026-05-12 | 19.68 |
| 2026-05-11 | 19.64 |
| 2026-05-08 | 19.54 |
| 2026-05-07 | 20.15 |
| 2026-05-06 | 20.19 |
| 2026-05-05 | 20.12 |
| 2026-05-04 | 20.01 |
| 2026-05-01 | 20.03 |
| 2026-04-30 | 20.31 |
| 2026-04-29 | 19.98 |
| 2026-04-28 | 20.15 |
| 2026-04-27 | 20.38 |
| 2026-04-24 | 20.54 |
| 2026-04-23 | 20.29 |
| 2026-04-22 | 20.39 |
| 2026-04-21 | 20.78 |
| 2026-04-20 | 20.94 |
| 2026-04-17 | 20.97 |
| 2026-04-16 | 20.71 |
| 2026-04-15 | 20.69 |
| 2026-04-14 | 20.63 |
| 2026-04-13 | 20.80 |
| 2026-04-10 | 20.48 |
| 2026-04-09 | 20.71 |
| 2026-04-08 | 20.90 |
| 2026-04-07 | 20.62 |
| 2026-04-06 | 21.17 |
| 2026-04-02 | 21.55 |
| 2026-04-01 | 21.72 |
| 2026-03-31 | 21.36 |
| 2026-03-30 | 21.13 |